Legal Representation
Attorney
Zuzanna M. Poprawski
USPTO Deadlines
Application History
18 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 22, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Feb 22, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Nov 9, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Nov 9, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Oct 16, 2009 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Oct 16, 2009 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
Oct 16, 2009 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
Aug 24, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Aug 24, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Jul 20, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jan 20, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 28, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 8, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Sep 25, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
Sep 25, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Sep 16, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 6, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 28, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes,and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Mixed vitamin preparations; Multi-vitamin preparations; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin enriched water; Vitamin fortified beverages; Vitamin preparations; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamins; Vitamins and vitamin preparations; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Herbal supplements; Meal replacement and dietary supplement drink mixes; Mineral supplements; Nutritional supplements; Powdered fruit-flavored dietary supplement drink mix; Powdered nutritional supplement drink mix; Dietetic foods adapted for medical use; Dietetic sugar for medical use; Dietary and nutritionally fortified food products adapted for medical use; Food for babies; Food for infants; Medicated baby powders; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Processed food adapted for medical purposes; Allergy medications; Biological preparations for medical purposes; Food for medically restricted diets; Gluten-free food to accommodate special medical and health conditions; Medicated confectionery; Medicinal herbal extracts for medical purposes; Stimulatory medications for use in weight reduction programs
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005